Project Number 3R01AG052510-03S1 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Escitalopram for Agitation in Alzheimer Disease - Blood Biomarker Banking Supplement Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator LYKETSOS, CONSTANTINE G Principal Investigator First Name CONSTANTINE Principal Investigator Last Name LYKETSOS Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-287: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp) FY Overall Cost $120,368 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Escitalopram for Agitation in Alzheimer's Disease
